// App-Quantinova.ai

55 : Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Researchers

Presenter

  • Dae-Young Kim

Principal Investigators

  • Sung-Doo Kim

  • Jae-Sook Ahn

  • Deok-Hwan Yang

  • Je-Jung Lee

  • Yang Soo Kim

  • Yeung-Chul Mun

  • Hawk Kim

  • Joon Ho Moon

  • Sang Kyun Sohn

  • Won Sik Lee

  • Jong-Ho Won

  • Jung-Hee Lee

  • Myoung Soo Hyun

  • Jinny Park

  • Jae Hoon Lee

  • Ho-Jin Shin

  • Hyeon Seok Eom

  • Gyeong Won Lee

  • Sung-Nam Lim

  • Young Jin Kim

  • Young-Uk Cho

  • Hyun-Sook Chi

  • Je-Hwan Lee

  • Kyoo-Hyung Lee

  • Dong-Hwan Kim

  • Kihyun Kim

  • Chul Won Jung

  • Inho Kim

  • Sung-Soo Yoon

  • Seonyang Park

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Pancreatitis

  • Arrhythmia

  • Hyperbilirubinemia

  • Philadelphia chromosome–positive (Ph+) ALL

  • Solid malignancies

Biomarkers

  • Alanine transaminase

  • Ph chromosome

Drug/Treatment

  • Daunorubicin

  • Prednisolone

  • Vincristine

  • Hydroxyzine

  • Nilotinib

  • lipase

  • Mofezolac

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved